Potential role for BCG in treatment of autoimmune diseases

BMJ (Online)

Volumn 355, Issue , 2016, Pages

  Curtis, Nigel ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

AUTOIMMUNE DISEASE; BCG VACCINATION; CANCER THERAPY; DRUG EFFECT; HUMAN; IMMUNOMODULATION; INFECTION PREVENTION; LETTER; NONHUMAN; PRIORITY JOURNAL; ANIMAL; AUTOIMMUNE DISEASES; WORLD HEALTH ORGANIZATION;

ANIMALS; AUTOIMMUNE DISEASES; BCG VACCINE; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 84997190873     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i6091     Document Type: Letter

References (5)

1. Higgins JPT, Soares-Weiser K, López-López JA, et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 2016;355:i5170. doi:10.1136/bmj.i5170 pmid:27737834.
2. Kandasamy R, Voysey M, McQuaid F, et al. Non-specific immunological effects of selected routine childhood immunisations: systematic review. BMJ 2016;355:i5225. doi:10.1136/ bmj.i5225 pmid:27737830.
3. Freyne B, Marchant A, Curtis N. BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms. Trans R Soc Trop Med Hyg 2015;109:46-51. doi:10.1093/trstmh/tru196 pmid:25573108.
4. Faustman DL, Wang L, Okubo Y, et al. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes. PLoS One 2012;7:e41756. doi:10.1371/journal.pone.0041756 pmid:22905105.
5. Ristori G, Romano S, Cannoni S, et al. Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS. Neurology 2014;82:41-8. doi:10.1212/01.wnl.0000438216. 93319.ab pmid:24306002.